Product Images Levetiracetam

NDC 36000-356-01 is a code for a medication called Levetiracetam in 0.75% Sodium Chloride Injection. It is used for intravenous infusion and comes in a 100 mL container. The medication should be infused over a period of 15 minutes. The container contains 1000 g etz SP (10 mamt, iter o inecton, USP), 750 mg sodium chioride, USP, 65 mg Gacl aceto aco, USP and buffered at approximately pH 5.5 with gl acetc acid, USP and 164 mg sodium acetate tiydrate. The usual dosage can be found in the package insert. It is important not to use plastic containers in series connections and to not dilute the medication further before use. The unit should be used promptly after opening the overwrap. The medication should be stored at 20° to 25°C (68° to 77°F) and any unused portion should be discarded. The container is not made with natural rubber latex, DEHP, or PVC. The product is made by Baxter Healthcare Corporation in Ireland.*

This is a description of a medication called Levetiracetam in 0.54% Sodium Chloride Injection. It is intended for intravenous infusion only and should be administered over a period of 15 minutes. Each 100 mL of the solution contains 1500 mg of Levetiracetam. The medication is stored at a temperature of 20°C to 25°C (68°F to 77°F). It comes in a single-dose bag and should not be further diluted before use. The container is not made with natural rubber latex, DEHP, or PVC. The manufacturer is Baxter Healthcare Corporation.*

This is a description of a medication called Levetiracetam. It is provided in the form of an injection for intravenous infusion. Each 100 mL of the injection contains 500 mg of levetiracetam, along with other ingredients such as sodium chloride and water for injection. The recommended dosage and storage instructions are not provided in the text, and it is mentioned that plastic containers should not be used in series connections. The medication should not be further diluted before use. The packaging is a single-dose bag, and any unused portion should be discarded. The container is free from natural rubber latex, DEHP, and PVC. The medication is manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA.*

This text provides information about the percentages of patients in different treatment groups. The percentages range from 0% to 45%. The data is presented for three different treatment groups, including a placebo group and two groups receiving different doses of Levetiracetam. The text mentions that the results for one of the treatment groups are statistically significant compared to the placebo. However, there is not enough information available to provide a more detailed description.*

This text appears to be a set of percentages and data related to patients and a specific medication called Levetiracetam. The percentages range from 100% to 10% and are labeled as "% of Patients". The text also mentions a placebo group with a sample size of 84 and indicates that the medication Levetiracetam had a statistically significant effect compared to the placebo. However, without further context or information, it is not possible to provide a more specific description or interpretation of the data.*

This is a description of a medication called Levetiracetam, which is administered by infusion. Each 100 mL of the medication contains 1500 mg of Levetiracetam and is mixed with water for injection, sodium chloride, glacial acetic acid, and sodium acetate trihydrate. The medication should be infused over a period of 15 minutes. The recommended dosage and storage instructions can be found in the package insert. It is important not to use plastic containers in series connections and not to dilute the medication further before use. The medication should be used promptly after removing the overwrap and any unused portion should be discarded. The container closure does not contain natural rubber latex. The medication is manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA and is made in Ireland. The lot and expiration information can be found on the solution container.*

This text appears to be the label or package insert for a medication called Levetiracetam in 0.82% Sodium Chloride Injection. The medication is administered through intravenous infusion and is used for a certain condition (not specified in the text). The recommended dosage and storage instructions are provided. The text also warns not to use plastic containers in series connections and advises against further dilution of the medication. The container closure is stated to not be made with natural rubber latex. The manufacturer is Baxter Healthcare Corporation, based in Deerfield, IL, USA, and the medication is made in Ireland.*